Merge PACS vs EchoNext
AI Verdict
Choose Merge PACS if…
Choose Merative Merge PACS if your multi-site health system requires an enterprise-level solution to consolidate imaging data, streamline radiology workflows, and integrate AI insights across various modalities and specialties. It is ideal for organizations seeking flexible deployment options (on-premise, cloud, hybrid) and advanced features like customizable worklists, enhanced diagnostic tools for mammography and image fusion, and real-time analytics for operational efficiency.
View Merge PACS →Choose EchoNext if…
Choose Pathway Labs EchoNext if your practice or health system needs an FDA-cleared AI tool to screen for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard ECGs. This tool is particularly well-suited for early detection and identifying patients who may require further diagnostic testing like echocardiograms, thereby bridging a critical gap in cardiovascular screening.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Merge PACS | EchoNext |
|---|---|---|
| Pricing | Contact vendor | Starts at $600/month |
| Deployment | On-premise, Cloud, Hybrid | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Merge PACSMerge PACS offers a highly customizable and composite worklist for multiple specialties, enhanced diagnostic workflows like Synchronized Priors Scrolling for mammography, and secure web-based access for remote reading, all contributing to a streamlined and efficient user experience. EchoNext, while valuable, is a more specialized tool integrated into another platform, suggesting a more focused, rather than broad, usability scope.
Clinical Value
EchoNextEchoNext is an FDA-cleared AI tool that has demonstrated superior accuracy in detecting hidden structural heart disease from standard ECGs compared to cardiologists, even those assisted by AI. This capability offers significant clinical value by enabling earlier detection of critical conditions that often go undiagnosed until symptomatic. Merge PACS, while integrating AI, is a broader PACS system, and its direct clinical impact from its own AI is not as specifically highlighted or validated as EchoNext's.
Pricing & Value
EchoNextEchoNext offers transparent tiered pricing starting at $600/month, with clear details on implementation fees and annual discounts. This transparency allows potential users to easily understand the cost structure. Merge PACS requires contacting the vendor for pricing details, making its value proposition less immediately clear.
Enterprise Readiness
Merge PACSMerge PACS is explicitly designed as an enterprise-level PACS, supporting multi-site health systems with flexible deployment options (on-premise, cloud, hybrid), integration with various healthcare IT systems (EMR/EHR, RIS, HIS, VNA), and robust security features. EchoNext, while available through a clinical decision support platform and targeting broad access, does not detail the same breadth of enterprise-level infrastructure and integration capabilities as Merge PACS.
Innovation
EchoNextEchoNext represents a significant innovation as the world's first FDA-cleared AI tool to detect multiple structural heart diseases from standard ECGs, outperforming human cardiologists in diagnostic accuracy. This introduces a new paradigm for early detection of heart disease. Merge PACS focuses on integrating third-party AI and enhancing existing radiology workflows, which is valuable but not as groundbreaking as EchoNext's core AI capability.
Support & Docs
Merge PACSMerge PACS provides extensive support resources, including a community hub, phone support, webinars, and detailed documentation such as DICOM Conformance Statements and release summaries. The availability of ongoing educational content and clear documentation for upgrades indicates a comprehensive support structure. While EchoNext is available through a platform, specific details on its direct support and documentation are not as readily available.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Merge PACS | EchoNext |
|---|---|---|
| Name | Merge PACS | EchoNext |
| Company | Merative | Pathway Labs |
| Description | An enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. It supports multi-modality diagnostic interpretation with flexible deployment options. | An FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. |
| Key Features | AI integration and readiness (single worklist access to 3rd party AI applications); Customizable, composite worklist for multiple specialties; Cloud-ready architecture (on-premise, cloud, hybrid deployment options); Enhanced diagnostic workflows (e.g., Synchronized Priors Scrolling for mammography, image fusion); Real-time analytics and dashboards (Merge Dashboards); Enterprise-wide image management and consolidation; Integration with EMR/EHR, RIS, HIS, and VNA systems; Secure web-based access for remote reading. | AI-powered ECG analysis; Detection of hidden structural heart disease; Identifies heart failure risk; Screens for valve disease; Detects pulmonary hypertension indicators; Utilizes standard 12-lead ECGs; FDA-cleared technology; Non-invasive diagnostic support. |
Videos
Demos, reviews, and walkthroughs featuring Merge PACS and EchoNext.